Skip to main content
Top
Published in: Current Hypertension Reports 11/2023

Open Access 10-10-2023 | Neurotomy | Correction

Correction to: Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review

Authors: Alberto Mazza, Fabio Dell’Avvocata, Gioia Torin, Francesca Bulighin, Yuri Battaglia, Fulvio Fiorini

Published in: Current Hypertension Reports | Issue 11/2023

Login to get access

Excerpt

Correction to: Current Hypertension Reports https://doi.org/10.1007/s11906-023-01264-2
Metadata
Title
Correction to: Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review
Authors
Alberto Mazza
Fabio Dell’Avvocata
Gioia Torin
Francesca Bulighin
Yuri Battaglia
Fulvio Fiorini
Publication date
10-10-2023
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 11/2023
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-023-01270-4

Other articles of this Issue 11/2023

Current Hypertension Reports 11/2023 Go to the issue

Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

Gut Microbiota and Its Role in the Brain-Gut-Kidney Axis in Hypertension

Mechanisms of Hypertension and Target-Organ Damage (JE Hall and ME Hall, Section Editors)

Role of Female Sex Hormones and Immune Response in Salt-Sensitive Hypertension Development: Evidence from Experimental Models

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine